Drug Profile
Metformin/teneligliptin - Handok Pharmaceuticals
Alternative Names: HL1511; Metformin/MP-513; MP-513/metformin; Tenelia M SR; Teneligliptin/metforminLatest Information Update: 27 Jun 2019
Price :
$50
*
At a glance
- Originator Handok Inc
- Class Antihyperglycaemics; Biguanides; Ketones; Piperazines; Pyrazoles; Small molecules; Thiazolidines
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus
Most Recent Events
- 27 Jun 2019 Chemical structure information added
- 31 Dec 2014 Preregistration for Type-2 diabetes mellitus in South Korea (PO, 1000mg/20mg) (Mitsubishi Tanabe Pharma pipeline, February 2015)
- 30 Nov 2014 Preregistration for Type-2 diabetes mellitus in South Korea (PO, 500mg/10mg) (Mitsubishi Tanabe Pharma pipeline, February 2015)